In recent years the volume of biological data has soared. Parallel to this growth, the need for developing data mining strategies has not met sufficiently. Bioinformaticians utilize different data mining techniques to obtain the required information they need from genomic, transcriptomic and proteomic databases to construct a gene regulatory network (GNR). One of the simplest mining approaches to construct a GNR is reading a great number of papers to configure a large network (for instance, a network with 50 nodes and 200 edges) which takes a lot of time and energy. Here we introduce an integrative method that combines information from transcriptomic data with sets of constructed pathways. A program was written in R that makes pathways from edgelists in different signaling databases. Furthermore, we explain how to distinguish false pathways from the correct ones using literature study or incorporating the biological information with gene expression results.
Introduction
Data mining tools like programming languages has become an urgent need in the era of big data. The more important issue is how and when these tools are required to be implemented.
Many Biological databases are available free for the users, but how researchers utilize these repositories depends on their computational techniques. Among these repositories, databases in NCBI are of great interest. GEO (Gene Expression Omnibus) [1] and SRA (Sequence Read Archive) [2] are two important genomic databases that archive microarray and next generation sequencing (NGS) data. Pubmed (US National Library of Medicine) is the library database in NCBI that stores most of the published papers in the area of biology and medicine. Biologists and computational biologists utilize these databases depend on their aim of study. Many researchers use information in the literature to construct a GNR. While other researchers use information in genomic repositories. Some of them obtain the information they want from signaling databases such as KEGG, STRING, OmniPath and so on without considering where this information comes from. A few researchers try to support data they find using other sources of information. Furthermore, many papers are present in the literature which illustrates paradox results. They contain molecular techniques data such as Real-time PCR, Immunoprecipitation, western blot and high-throughput techniques. As a result, a deep insight into the type of biological context is needed to choose the correct answer.
In this study we propose an integrative method to use information in genomic repositories, signaling databases and literature using the knowledge of data mining and computational techniques and knowledge of molecular biology. This study was concentrated on protooncogene c-Src which has been implicated in progression and metastatic behavior of human cancers including those of colon and breast [3] [4] [5] [6] . Moreover, this gene is a target of many chemotherapy drugs, so revealing the new mechanisms that trigger cells to go under Epithelial to Mesenchymal Transition (EMT) would help design more pertinent drugs for different carcinomas and adenocarcinomas.
Boolean relationships between molecular components of cells suffer from too much simplicity regarding the complex identity of molecular interactions. In the meanwhile, many interactions can be connected together to offer a pathway. To reach from an oncogene to a junctional protein, millions of pathways can be configured if only information for most reported genes is considered. To determine the right ones among thousands of pathways, they should be validated based on the type of biological context and valid experimental results. Therefore, in this study, two transcriptomic datasets were utilized in which MCF10A normal human adherent breast cell lines were equipped with ER-Src system. These cells were treated with tamoxifen to witness the overactivation of Src and gene expression pattern in different time points were analyzed in these cell lines. Because during EMT process many junctional proteins or related proteins and kinases are deregulated in expression or activation, we tried to find the most affected genes in these cells and all possible connections between Src and DEGs. To be more precise about the result of analysis, we found two transcriptomic datasets obtained from two different technologies, microarray and NGS. Then we only considered DEGs which were common in both datasets. Moreover, we used information in KEGG and OmniPath databases to construct pathways from Src to DEGs (Differentially Expressed Genes) and between DEGs themselves. Then information from expression results and those from the papers were utilized to select the possible correct pathways.
Methods

Database Searching and recognizing pertinent experiments
Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) and Sequence Read Archive (https://www.ncbi.nlm.nih.gov/sra) databases were searched to detect experiments containing high-quality transcriptomic samples concordance to the study design. Homo sapiens, SRC, overexpression, overactivation are the keywords utilized in the search.
Microarray raw data with accession number GSE17941 was downloaded from GEO database.
RNA-seq raw data with SRP054971 (GSE65885 GEO ID) accession number was downloaded from SRA database. In both studies, either tamoxifen was used to overactivate Src or ethanol was used as control in in MCF10A cell line containing ER-Src system.
Microarray Data Analysis.
R software was used to import and analyze the data for each dataset separately. The preprocessing step involving background correction and probe summarization was done using RMA method in Affy package [7] . Absent probesets were also identified using "mas5calls" function in this package. If a probeset contained more than two absent values, that one was regarded as absent and removed from the expression matrix. Besides, outlier samples were identified and removed using PCA and hierarchical clustering approaches.
Next, data were normalized using quantile normalization method. Many to Many problem which is mapping multiple probesets to the same gene symbol was solved using nsFilter function in genefilter package [8] . This function selects the probeset with the highest interquartile range (IQR) as the representative of other probesets mapping to the same gene symbol. After that, LIMMA R package was utilized to identify differentially expressed genes (DEGs) [9] .
RNA-seq Data Analysis
Samples are related to the study where they illustrated that many pseudogenes and lncRNAs are translated into functional proteins [10] . We selected seven samples of this study useful for the aim of our research and their SRA IDs are from SRX876039 to SRX876045. Bash shell commands in Ubuntu Operating System were used to reach counted expression files from fastq files. Quality control step was done on each sample separately using fastqc function in FastQC module. Next, Trimmomaticsoftware was used to trim reads. 10 bases from the reads head were cut and bases with quality less than 30 were removed from the reads and reads with the length of larger than 36 base pair (BP) were kept. Then, trimmed files were aligned to the hg38 standard fasta reference sequence using HISAT2 software to create SAM files. SAM files converted into BAM files using Samtools package. In the last step, BAM files and a GTF file containing human genome annotation were given to featureCounts program to create counted files. After that, files were imported into R software and all samples were attached together and an expression matrix constructed with 59412 variables and seven samples. Rows with sum values less than 7 were removed from the expression matrix and RPKM method in edger R package was used to normalize the remaining rows [11] . Finally,in order to identify DEGs, LIMMA R package was used. Finally, correlation-based hierarchical clustering was done using factoextra r package [14] .
Pathway Construction from Signaling Databases
25 human KEGG signaling networks containing Src element were downloaded from KEGG signaling database [12] . Pathways were imported into R using "KEGGgraph" package [13] and using programming techniques, all the pathways were combined together. Loops were omitted and only directed inhibition and activation edges were selected. In addition, a very large edgelist containing all literature curated mammalian signaling pathways were constructed from OmniPath database [14] . To do pathway discovery, a script was developed in R using igraph package [15] by which a function was created with four arguments. The first argument accepts an edgelist, second argument is a vector of source genes, third argument is a vector of target genes and forth argument receives a maximum length of pathways.
Results
Data Preprocessing and Identifying Differentially Expressed Genes
Almost 75% of probesets were regarded as absent and left out from the expression matrix to avoid technical errors. To be more precise in the preprocessing step, outlier sample detection was conducted using PCA (using eigenvector 1 (PC1) and eigenvector 2 (PC2)) and hierarchical clustering. Figure1A illustrates the PCA plot for the samples in GSE17941 study. Sample GSM448818 in time point 36-hour, was far away from the other samples. In the hierarchical clustering approach, Pearson correlation coefficients between samples were subtracted from one for measurement of the distances. Then, samples were plotted based on their Number-SD. To get this number for each sample, the average of whole distances is subtracted from distances average in all samples, then results of these subtractions are normalized (divided) by the standard deviation of distance averages [16] . Sample GSM448818_36h with Number-SD less than negative two was regarded as the outlier and removed from the dataset ( Figure 1B ). There were 21 upregulated and 3 downregulated common DEGs between two datasets. Figure 2 This demonstrates that the preprocessed datasets are of sufficient quality for the analysis. 
Pathway Mining
Since, the obtained DEGs are the results of analyzing datasets from two different genomic technologies, there is a high probability of affecting Src activation on these 24 genes. So, we continued our analysis in KEGG signaling networks containing Src to find the Boolean relationships between Src and these genes. To this end, we developed a pathway mining approach which extracts all possible pathways between two components in a signaling network. For pathway discovery, a large edgelist with 1025 nodes and 7008 edges was constructed from 25 downloaded pathways (supplementary file 1). To reduce number of pathways, only shortest pathways were regarded in the analysis. Just two DEGs were presented in the constructed KEGG network namely TIAM1 and ABLIM3. Table1 shows all the pathways between Src and these two genes. They are two-edge distance Src targets which their expression is affected by Src over-activation. TIAM1 was upregulated while ABLIM3 was down-regulated in Figure 2 . In Pathway number 1, Src induces CDC42 and CDC42 induces TIAM1. Therefore, a total positive interaction is yielded from Src to TIAM1.
On the one hand ABLIM3 was down-regulated in Figure 2 , On other hand this gene could positively be induced by Src activation in four different ways in Table 1 . This paradox results, firstly would be a demonstration that Boolean interpretation of relationships suffers from lack of reality which simplifies the system artificially and ignores all the kinetics of interactions. Secondly, information in the signaling databases comes from different experimental sources and biological contexts. Consequently, a precise biological interpretation is required when combining information from different studies to construct a gene regulatory network.
Table1: Discovered Pathways from Src gene to TIAM1 and ABLIM3 genes. In the interaction column, "1" means activation and "-1" means inhibition. ID column presents the edge IDs (indexes) in the KEGG edgelist. Pathway column represents the pathway number.
Due to the uncertainty about the discovered pathways in KEGG, a huge human signaling edgelist was constructed from OmniPath database (http://omnipathdb.org/interactions).
Constructed edgelist is composed of 20853 edges and 4783 nodes. 14 DEGs were found in the edgelist which eleven of them were found to be Src targets. 11 Shortest pathways with maximum length of three and minimum length of one were discovered illustrated in Table2.
Unfortunately, ABLIM1 gene was not found in the edgelist. So, we couldn't further its pathway analysis with Src. But Tiam1 would be a direct (one-edge distance) target of Src in Pathway 1. FHL2 could be induced or suppressed by Src based on Pathways 3 and 4 respectively. However, FHL2 is among the upregulated genes by Src. Therefore, the necessity of biological interpretation of each edge is required to discover the correct pathway.
Table2: Discovered pathways from Src to the DEGs in OmniPath edgelist. Figure 3 depicts the expression values for TIAM1, ABLIM3, RGS2, and SERPINB3 in these time points. RGS2 and SERPINB3 witnessed a significant expression growth in tamoxifen-treated cells at the two datasets.
Time Series Gene Expression Analysis
Time-course expression patterns of all DEGs are presented in supplementary file 2. 
Clustering
We applied hierarchical clustering on expression of all DEGs just in Src over-activated samples. Pearson correlation coefficient was used as the distance in the clustering method.
Clustering results were different between the two datasets therefore, we applied this method only on SRP054971 Dataset (Figure4). We hypothesized that genes in close distances in each cluster may have relationships with each other, so we applied pathway analysis on four DEGs in Figure 3 . Among them, Only TIAM1 and RGS2 were present in OmniPath edgelist. As a result, we extracted pathways from TIAM1 and RGS2 to their cluster counterparts. All these pathways are presented in supplementary file 3. 
Discussion
Analyzing the relationships between Src and all these 24 obtained DEGs were of too much biological information and also were beyond the goal of this study, Therefore, we considered only TIMA1 and ABLIM3 and two highly affected genes in tamoxifen-treated cells namely RGS2 and SERPINB3 presented in Figure3. So, more investigations are needed to be done on the rest of the genes to see how and why all these genes are affected by Src. That's important because of some reports in multiple studies that Src alone is not sufficient to totally promote EMT []. Importantly, Src is the target of many chemotherapy drugs, so evaluate the function of affected genes is vital for drug design.
ABLIM3 (Actin binding LIM protein 1) is a component of adherent junctions (AJ) in epithelial cells and hepatocytes. Its down-regulation in Figure3 leads to the weakening of cell-cell junctions [17] .
Rac1 is a mall GTP-binding protein (G protein) that its activity is strongly elevated in Src-transformed cells. It is a critical component of the pathways connecting oncogenic Src with cell transformation [18] which also was presented by edge E03150 in pathway number 5 in table1. Tiam1 is a guanine nucleotide exchange factor that is phosphorylated in tyrosine residues in cells transfected with oncogenic Src. Therefore, it could be a direct target of Src which has not been reported in 25 KEGG networks but this relationship was found in Table2 pathway number 1. Tiam1 cooperates with Src to induce activation of Rac1 in vivo and formation of membrane ruffles. Expression induction of TIAM1 in Figure 3 would explain how Src bolster its cooperation with TIAM1 to induce EMT and cell migration [19] . Src induces cell transformation through both Ras-ERK and Rho family of GTPases dependent pathways [20, 21] . Rac1 downregulation decreases cell EMT and proliferation capability in vitro and in vivo [20] .
Par polarity complex (Par3-Par6-aPKC) regulates the establishment of cell polarity. CDC42 and Rac control the activation of the Par polarity complex. TIAM1 is an activator of Rac and a crucial component of the Par complex in regulating epithelial (apical-basal) polarity [22] . Based on the KEGG human Chemokine signaling pathway with map ID hsa04062, this complex is activated by CDC42. So, regarding the information in pathway number 7, there is a possibility that Src-induced activation of Tiam1 is also mediated by CDC42.
SERPINB3 is a serine protease inhibitor that is over-expressed in epithelial tumors to inhibit apoptosis. This gene induces deregulation of cellular junctions by suppression of E-cadherin and enhancement of cytosolic B-catenin supported by features of epithelial-mesenchymal transition [23] . Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells and this upregulation under hypoxic conditions requires intracellular generation of ROS [24] . Moreover, there is a positive feedback that is SERPINB3 up-regulates HIF-1α and -2α in liver cancer cells [25] .
Therefore, these positive mechanisms would help cancer cells to augment invasiveness properties and proliferation. Unfortunately, this gene did not exist neither in OmniPath nor in KEGG edgelists. Its significant expression induction and its mentioned mechanism in promoting metastasis would explain one of the mechanisms that Src triggers invasive behaviors in cancer cells.
Regulator of G protein 2 or in short RGS2 is a GTPase activating protein (GAP) for G alpha subunits of heterotrimeric G proteins. Increasing the GTPase activity of G protein alpha subunit drives their inactive GDP binding form [26] . Although this gene was highly up-regulated in Src-overexpressed cells, its expression has been found to be reduced in different cancers such as prostate and colorectal cancer [27, 28] . This might be one of the contradictory effects of Src on promoting EMT. In Table 2 , Pathway number 7 connects Src to RGS2. ErbB2-mediated cancer cell invasion in breast cancer samples is practiced through direct interaction and activation of PRKCA/PKCα by Src [29] . PKG1/PRKG1 is phosphorylated and activated by PKC following phorbol 12-myristate 13-acetate (PMA) treatment [30] . GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Inhibition of phosphoinositide (PI) hydrolysis in smooth muscles is done via phosphorylation of RGS2 by PRKG and its association with Gα-GTP subunit of G proteins. In fact, PRKG over-activates RGS2 to accelerate Gα-GTPase activity and enhance Gαβγ (complete G protein) trimer formation [31] . Consequently, there would be a possibility that Src can induce RGS2 protein activity based on pathway number 7 and given information about each edge. Based on Figure 3 , Src induces the expression of RGS2 so maybe the mediators in pathway number 7, has a role in induction of this gene or It might be possible that RGS2 has auto-regulatory effects on its expression. SERPINB3 and ABLIM3 were not present in the OmniPath edgelist, so we conducted pathway mining from TIAM1 and RGS2 to their cluster counterparts and between TIAM1 and RGS2 (supplementary file 3). The results show that, there could be a relationship between PNRC1, ETS2 and FATP toward RGS2. All of these relationships are set by PRKCA and PRKG genes at the end of pathways.Nevertheless, PNCR1 makes shorter pathways and is worth more investigation. JUNB and PDP1 each made a relationship with TIAM1. The discovered pathway from JUNB to TIAM1 is mediated by EGFR and SRC demonstrating that SRC could induce its expression by induction of JUNB.
Moreover, there are two pathways from TIAM1 to RGS2 and from RGS2 to TIAM1 with the same length which are worth investigating.
